Page last updated: 2024-08-17

carbostyril and Pneumonia, Viral

carbostyril has been researched along with Pneumonia, Viral in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Baby, K; Maity, S; Mehta, CH; Nayak, UY; Nayak, Y; Suresh, A1
Bai, L; Cao, B; Gonzalez, R; Guo, P; Liu, YM; Ren, LL; Song, SF; Wang, C; Wang, JW; Yin, YD; Zhang, JZ; Zhang, YY; Zhao, F1

Other Studies

2 other study(ies) available for carbostyril and Pneumonia, Viral

ArticleYear
Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An
    F1000Research, 2020, Volume: 9

    Topics: Antiviral Agents; Betacoronavirus; Catalytic Domain; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Molecular Docking Simulation; Pandemics; Pentanoic Acids; Pneumonia, Viral; Pyridines; Quinolines; Quinolones; RNA-Dependent RNA Polymerase; SARS-CoV-2

2020
Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11

    Topics: Adult; Age Factors; Anti-Bacterial Agents; beta-Lactams; China; Community-Acquired Infections; Female; Humans; Legionella pneumophila; Macrolides; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Viral; Quinolones; Sputum; Streptococcus pneumoniae; Treatment Outcome

2010